Alpha Tau Medical (DRTS) Other financing activities (2021 - 2022)

Alpha Tau Medical (DRTS) posted quarterly Other financing activities of $1.9 million for Q2 2022, up 41.26% on a QoQ basis from $1.3 million in Q1 2022.

Alpha Tau Medical (DRTS) Other financing activities (2021 - 2022) Analysis & Trends

Alpha Tau Medical (DRTS) has reported Other financing activities for 2 consecutive years, with $1.9 million the latest figure, recorded in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alpha Tau Medical 1.19 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2022 1.91 Mn
Jun 30, 2022 1.91 Mn
Mar 31, 2022 1.35 Mn
Mar 31, 2022 1.35 Mn
Mar 31, 2021 1,000.00
Mar 31, 2021 1,000.00